GE HealthCare Technologies (NASDAQ:GEHC) Rating Increased to Moderate Buy at Royal Bank Of Canada

GE HealthCare Technologies (NASDAQ:GEHC) was upgraded by investment analysts at Royal Bank Of Canada to a “moderate buy” rating in a report released on Tuesday,Zacks.com reports.

Several other brokerages have also issued reports on GEHC. Mizuho dropped their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. BTIG Research cut their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Piper Sandler lowered their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $80.20.

GE HealthCare Technologies Trading Up 5.1%

NASDAQ:GEHC opened at $63.72 on Tuesday. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $28.99 billion, a PE ratio of 15.24, a price-to-earnings-growth ratio of 1.65 and a beta of 0.74. The firm’s 50 day moving average is $65.04 and its 200 day moving average is $74.28. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the previous year, the company posted $1.01 EPS. GE HealthCare Technologies’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts expect that GE HealthCare Technologies will post 4.89 earnings per share for the current year.

Insider Activity

In related news, Director Kevin Lobo acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were bought at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director owned 14,363 shares in the company, valued at $921,817.34. This trade represents a 229.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Watkin Phoebe L. Yang acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the acquisition, the director directly owned 13,702 shares in the company, valued at $863,363.02. This represents a 7.87% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in GEHC. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at about $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. grew its stake in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC grew its stake in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.